Alector (ALEC) Net Cash Flow Growth (1y) (2019 - 2026)
Alector (ALEC) Net Cash Flow Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,184.45 Bn | 68,184.17 Bn | - | -88.82% |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 474.39 Bn | 469.59 Bn | 1.35 Bn | 301.06% |
| 5 | Vertex Pharmaceuticals | 123.45 Bn | 116.21 Bn | 2.59 Bn | 453.08% |
| 6 | Regeneron Pharmaceuticals | 69.92 Bn | 61.16 Bn | 3.31 Bn | -125.22% |
| 7 | Belite Bio | 63.43 Bn | 63.43 Bn | - | - |
| 8 | Argenx Se | 56.67 Bn | 51.49 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 38.08 Bn | 38.08 Bn | - | - |
| 10 | Alector | 173.63 Mn | -32.89 Mn | - | 125.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 125.36% |
| Dec 31, 2025 | -178.82% |
| Sep 30, 2025 | 405.53% |
| Jun 30, 2025 | 127.18% |
| Mar 31, 2025 | 347.23% |
| Dec 31, 2024 | 86.00% |
| Sep 30, 2024 | 64.89% |
| Jun 30, 2024 | 60.89% |
| Mar 31, 2024 | -104.86% |
| Dec 31, 2023 | 8.36% |
| Sep 30, 2023 | -347.19% |
| Jun 30, 2023 | 77.36% |
| Mar 31, 2023 | -67.14% |
| Dec 31, 2022 | 84.04% |
| Sep 30, 2022 | -96.94% |
| Jun 30, 2022 | -1,981.11% |
| Mar 31, 2022 | 106.59% |
| Dec 31, 2021 | -435.22% |
| Sep 30, 2021 | 5,295.68% |
| Jun 30, 2021 | 121.94% |